Vinks AA - Search Results

1

Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1.

Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AA. Scott JR, et al. Among authors: vinks aa. Ther Drug Monit. 2013 Jun;35(3):332-7. doi: 10.1097/FTD.0b013e318286dd3f. Ther Drug Monit. 2013. PMID: 23666574 Free PMC article.

2

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home.

Vinks AA, Touw DJ, Heijerman HG, Danhof M, de Leede GP, Bakker W. Vinks AA, et al. Ther Drug Monit. 1994 Aug;16(4):341-8. doi: 10.1097/00007691-199408000-00002. Ther Drug Monit. 1994. PMID: 7974622

3

Suggestions for the optimization of the initial tobramycin dose in adolescent and adult patients with cystic fibrosis.

Touw DJ, Vinks AA, Heijerman HG, Hermans J, Bakker W. Touw DJ, et al. Among authors: vinks aa. Ther Drug Monit. 1994 Apr;16(2):125-31. doi: 10.1097/00007691-199404000-00003. Ther Drug Monit. 1994. PMID: 8009558

4

Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.

Touw DJ, Vinks AA, Heijerman HG, Bakker W. Touw DJ, et al. Among authors: vinks aa. Ther Drug Monit. 1993 Feb;15(1):52-9. doi: 10.1097/00007691-199302000-00010. Ther Drug Monit. 1993. PMID: 8451782

5

Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis.

Touw DJ, Vinks AA, Heijerman HG, Bakker W. Touw DJ, et al. Among authors: vinks aa. Ther Drug Monit. 1996 Apr;18(2):118-23. doi: 10.1097/00007691-199604000-00002. Ther Drug Monit. 1996. PMID: 8721272

6

Creatinine clearance as predictor of tobramycin elimination in adult patients with cystic fibrosis.

Town DJ, Vinks AA, Jacobs F, Heijerman HG, Bakker W. Town DJ, et al. Among authors: vinks aa. Ther Drug Monit. 1996 Oct;18(5):562-9. doi: 10.1097/00007691-199610000-00007. Ther Drug Monit. 1996. PMID: 8885120

7

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.

van Lent-Evers NA, Mathôt RA, Geus WP, van Hout BA, Vinks AA. van Lent-Evers NA, et al. Among authors: vinks aa. Ther Drug Monit. 1999 Feb;21(1):63-73. doi: 10.1097/00007691-199902000-00010. Ther Drug Monit. 1999. PMID: 10051056

8

Can tobramycin inhalation be improved with a jet nebulizer?

Le Brun PP, Vinks AA, Touw DJ, Hekelaar N, Mannes GP, Brimicombe RW, Frijlink EH, Heijerman HG. Le Brun PP, et al. Among authors: vinks aa. Ther Drug Monit. 1999 Dec;21(6):618-24. doi: 10.1097/00007691-199912000-00007. Ther Drug Monit. 1999. PMID: 10604822 Clinical Trial.

9

NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates.

de Hoog M, Schoemaker RC, van den Anker JN, Vinks AA. de Hoog M, et al. Among authors: vinks aa. Ther Drug Monit. 2002 Jun;24(3):359-65. doi: 10.1097/00007691-200206000-00006. Ther Drug Monit. 2002. PMID: 12021626

10

Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.

Vinks AA, Den Hollander JG, Overbeek SE, Jelliffe RW, Mouton JW. Vinks AA, et al. Antimicrob Agents Chemother. 2003 Feb;47(2):541-7. doi: 10.1128/AAC.47.2.541-547.2003. Antimicrob Agents Chemother. 2003. PMID: 12543656 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters